US 7374936
Method and means for site directed therapy
granted A61KA61K51/1045A61K51/1093
Quick answer
US patent 7374936 (Method and means for site directed therapy) held by Actinium Phamaceuticals, Inc. expires Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Actinium Phamaceuticals, Inc.
- Grant date
- Tue May 20 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 15 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K51/1045, A61K51/1093